ERIC BJERKHOLT - 08 Nov 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
08 Nov 2024
Net transactions value
+$9,997
Form type
4
Filing time
14 Nov 2024, 16:34:32 UTC
Previous filing
12 Sep 2024
Next filing
16 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $9,997 +475 +1.4% $21.05 33,279 08 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 475 shares by the Reporting Person on November 8, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.